Evidence map›Paper›PMID 33747205›Full record

ArticleOncology letters2021

Status of CHEK2 and p53 in patients with early-onset and conventional gastric cancer.

Julita Machlowska, Przemysław Kapusta, Małgorzata Szlendak, Anna Bogdali, Folkert Morsink, Paweł Wołkow, Ryszard Maciejewski, G Johan A Offerhaus, Robert Sitarz

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Inactivation ofLife (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Julita MachlowskaCenter for Medical Genomics OMICRON, Jagiellonian University Medical College, 31-034 Kraków, Poland.
Przemysław KapustaCenter for Medical Genomics OMICRON, Jagiellonian University Medical College, 31-034 Kraków, Poland.
Małgorzata SzlendakDepartment of Human Anatomy, Medical University of Lublin, 20-090 Lublin, Poland.
Anna BogdaliCenter for Medical Genomics OMICRON, Jagiellonian University Medical College, 31-034 Kraków, Poland.
Folkert MorsinkDepartment of Pathology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Paweł WołkowCenter for Medical Genomics OMICRON, Jagiellonian University Medical College, 31-034 Kraków, Poland.
Ryszard MaciejewskiDepartment of Human Anatomy, Medical University of Lublin, 20-090 Lublin, Poland.
G Johan A OfferhausDepartment of Human Anatomy, Medical University of Lublin, 20-090 Lublin, Poland.
Robert SitarzDepartment of Human Anatomy, Medical University of Lublin, 20-090 Lublin, Poland.
Jagiellonian University · PLMedical University of Lublin · PLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) is the fourth most common cause of cancer-associated death. Based on the age at diagnosis, GC is divided into early-onset GC (EOGC; ≤45 years) and conventional GC (CGC; >45 years). Mutations in the cell cycle checkpoint kinase 2 (

Indexed as

checkpoint kinase 2early-onset subtypegastric cancerimmunohistochemistrynext-generation sequencingp53

Identifiers

PMID33747205
PMCPMC7967923
OpenAlexW3135352953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.